Package Leaflet: Information for the Patient
Nexilina 100 mg Film-Coated Tablets EFG
Lacosamide
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet:
What is Nexilina
This medication contains lacosamide, which belongs to a group of medications called
"antiepileptic medications". These medications are used to treat epilepsy.
You have been prescribed this medication to reduce the number of seizures you experience.
What Nexilina is used for
Nexilina is used:
Do not take Nexilina
(listed in section 6). If you are unsure, consult your doctor.
Do not take this medication if any of the above applies to you. If you are unsure, consult your doctor or pharmacist before taking this medication.
Warnings and Precautions
Consult your doctor before starting to use this medication if:
Children
Lacosamide is not recommended in children under 2 years of age with epilepsy characterized by the occurrence of partial-onset seizures, nor in children under 4 years of age with primary generalized tonic-clonic seizures. This is because it is not yet known if it is effective and safe for children in this age group.
Other medications and Nexilina
Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medication.
In particular, tell your doctor or pharmacist if you are taking any of the following medications that affect the heart, as lacosamide may also affect the heart.
If any of the above applies to you (or you are unsure), talk to your doctor or pharmacist before taking this medication.
Also, inform your doctor or pharmacist if you are taking any of the following medications, as they may also increase or decrease the effect of lacosamide in your body.
If any of the above applies to you (or you are unsure), talk to your doctor or pharmacist before taking Nexilina.
Taking Nexilina with alcohol
As a precaution, do not take this medication with alcohol.
Pregnancy and breastfeeding
Women of childbearing age should discuss the use of contraceptives with their doctor.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Lacosamide is not recommended during pregnancy, as its effects on pregnancy and the fetus are not yet known.
Do not breastfeed while taking Nexilina, as lacosamide passes into breast milk. Ask your doctor for advice immediately if you are pregnant or plan to become pregnant. They will help you decide whether to take lacosamide or not.
Do not stop treatment without talking to your doctor first, as this may increase the risk of seizures (epilepsy). Worsening of your condition may also harm the fetus.
Driving and using machines
Do not drive, ride a bicycle, or use any tools or machines until you know if this medication affects you. The reason is that lacosamide may cause dizziness or blurred vision.
This medication may cause allergic reactions because it contains Orange Yellow S (E110). It may cause asthma, especially in patients allergic to acetylsalicylic acid.
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again. Another form of this medication may be more suitable for children; consult your doctor or pharmacist.
Taking Nexilina
Normally, you will start with a low dose each day, and your doctor will gradually increase the dose over several weeks. When you reach the dose that works well for you, called the "maintenance dose", you will take the same amount every day. Lacosamide is used as long-term treatment. You will need to continue taking lacosamide until your doctor tells you to stop.
How much to take
The following are the usual recommended doses of lacosamide for different age and weight groups. Your doctor may prescribe a different dose if you have kidney or liver problems.
Adolescents and children weighing 50 kg or more and adults
When taking Nexilina alone:
The usual starting dose is 50 mg twice a day.
Your doctor may also prescribe a starting dose of 100 mg of lacosamide twice a day. Your doctor may increase the dose you take twice a day by 50 mg each week, until you reach a maintenance dose between 100 mg and 300 mg twice a day.
When taking Nexilina with other antiepileptic medications:
The usual starting dose is 50 mg twice a day.
Your doctor may increase the dose you take twice a day by 50 mg each week, until you reach a maintenance dose between 100 mg and 200 mg twice a day.
If you weigh 50 kg or more, your doctor may start lacosamide treatment with a single "loading dose" of 200 mg. You would then start taking the continuous maintenance dose 12 hours later.
Children and adolescents weighing less than 50 kg
The dose depends on body weight. Treatment is usually started with the oral solution and only switched to tablets if the patient is able to take them and get the correct dose with tablets of different concentrations. Your doctor will prescribe the pharmaceutical form that best suits you.
If you take more Nexilina than you should
If you have taken more lacosamide than you should, consult your doctor immediately. Do not attempt to drive.
You may experience:
If you forget to take Nexilina
If you stop taking Nexilina
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, lacosamide may cause side effects, although not everyone gets them.
Side effects on the nervous system, such as dizziness, may be greater after a single "loading dose".
Tell your doctor or pharmacist if you experience any of the following effects:
Very common: may affect more than 1 in 10 patients
Common: may affect up to 1 in 10 patients
shaking (tremor), tingling (paresthesia), or muscle spasms, falling easily, and bruising;
Uncommon: may affect up to 1 in 100 patients
Rare: may affect up to 1 in 1,000 patients
Frequency not known: cannot be estimated from available data
Other side effects in children
Additional side effects observed in children were fever (pyrexia), runny nose (nasopharyngitis), sore throat (pharyngitis), decreased appetite, behavioral changes, abnormal behavior, and lack of energy (lethargy). Drowsiness (somnolence) is a very common side effect in children and may affect more than 1 in 10 children.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report side effects directly through the Spanish Medicines Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the carton and blister after CAD/EXP. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of via wastewater or household waste. Return the containers and any unused medication to the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the containers and any unused medication. This will help protect the environment.
Nexilina Composition
The active ingredient is lacosamide.
Each Nexilina 100 mg tablet contains 100 mg of lacosamide.
The other ingredients are:
Core of the tablet: microcrystalline cellulose, hydroxypropylcellulose, hydroxypropylcellulose (slightly substituted), colloidal anhydrous silica, crospovidone, magnesium stearate.
Coating: poly(vinyl alcohol), macrogol, talc, titanium dioxide (E171), yellow iron oxide (E172), quinoline yellow (E104), and orange yellow S (E110).
Appearance of the Product and Package Contents
Nexilina 100 mg are film-coated, oval tablets, yellow in color, marked with "100" on one side and smooth on the other side. Approximate dimensions: 5.4 x 12.1 mm.
Nexilina 100 mg is available in blister packs of 56 film-coated tablets.
Marketing Authorization Holder and
Adventia Pharma, S.L.
Calle Viera y Clavijo, 30, 2º
35002 Las Palmas de Gran Canaria (Spain)
Local Representative
Atika Pharma, S.L.
Calle Viera y Clavijo, 30, 2º
35002 Las Palmas de Gran Canaria (Spain)
Manufacturer
Merckle GmbH,
Blaubeuren,
Germany
Or
TEVA Gyógyszergyár Zrt.,
Pallagi út 13
H-4042, Debrecen
Hungary
Date of the last revision of this package leaflet:October 2022
Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/